Practical guidelines for multiplicity adjustment in clinical trials.
about
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalA call for transparent reporting to optimize the predictive value of preclinical researchPeştera cu Oase 2 and the cranial morphology of early modern EuropeansSleep patterns, sleep instability, and health related quality of life in parents of ventilator-assisted childrenThe Melbourne Family Support Program: evidence-based strategies that prepare family caregivers for supporting palliative care patients.Are there two forms of isometric muscle action? Results of the experimental study support a distinction between a holding and a pushing isometric muscle function.Cell phone intervention for you (CITY): A randomized, controlled trial of behavioral weight loss intervention for young adults using mobile technology.Effects of acupuncture treatment on poststroke motor recovery and physical function: a pilot study.Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levelsDesign considerations and rationale of a multi-center trial to sustain weight loss: the Weight Loss Maintenance TrialDifferential impact of serotonin transporter activity on temperament and behavior in persons with a family history of alcoholism in the Oklahoma Family Health Patterns Project.Post-discharge follow-up visits and hospital utilization by Medicare patients, 2007-2010.Statistical multiplicity in systematic reviews of anaesthesia interventions: a quantification and comparison between Cochrane and non-Cochrane reviews.A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder.A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.Reporting of analyses from randomized controlled trials with multiple arms: a systematic review.The Association between Depressive Symptoms and Physical Diseases in Switzerland: A Cross-Sectional General Population StudyPre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.Protocol for the Northern Manhattan Diabetes Community Outreach Project. A randomised trial of a community health worker intervention to improve diabetes care in Hispanic adultsA randomised controlled trial of a lifestyle behavioural intervention for patients with low back pain, who are overweight or obese: study protocolOutcome Assessments in Clinical Trials of Cryptococcal Meningitis: Considerations on Use of Early Fungicidal Activity as a Potential Surrogate Endpoint for All-Cause Mortality.Randomised controlled trial of referral to a telephone-based weight management and healthy lifestyle programme for patients with knee osteoarthritis who are overweight or obese: a study protocol.Neonatal resuscitation adhering to oxygen saturation guidelines in asphyxiated lambs with meconium aspirationPACE--the first placebo controlled trial of paracetamol for acute low back pain: statistical analysis plan.Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register.Effectiveness of a healthy lifestyle intervention for low back pain and osteoarthritis of the knee: protocol and statistical analysis plan for two randomised controlled trials.Housing First Improves Adherence to Antipsychotic Medication Among Formerly Homeless Adults With Schizophrenia: Results of a Randomized Controlled Trial.The effects of changing dairy intake on trans and saturated fatty acid levels- results from a randomized controlled studyPre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.Multifunctional food: medical evidence and methodological notes on substantiating health claims.Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?Bayesian penalized log-likelihood ratio approach for dose response clinical trial studies.Recommendations on multiple testing adjustment in multi-arm trials with a shared control group.Relationship between fear of falling and outcomes of an inpatient geriatric rehabilitation population--fear of the fear of falling.An introduction to multiplicity issues in clinical trials: the what, why, when and how.Assessment of a quantitative metric for 4D CT artifact evaluation by observer consensusCombination antifungal therapy for cryptococcal meningitisA Randomized Controlled Trial of a Mobile Health Intervention to Promote Self-Management After Lung Transplantation.Misspecification of Cox regression models with composite endpoints.
P2860
Q24288920-23E46E27-67AE-4CAA-9EBB-7D9DCE34F445Q24289327-6DD58E4B-4A99-4ABA-921C-45EB6BA4E800Q24682643-98888113-24B9-4B7A-AB16-96DF182103B2Q28389010-2DC6B08E-28BE-4642-8321-7B927142DFCFQ30217071-190C9054-3546-4C25-8A0D-B3C246ABB919Q30356561-CD7C2747-2262-4620-9992-034EF41546A7Q30673510-8315D3DF-6F48-4333-8AE7-28054B6B7849Q33208866-E62508FC-6101-4C30-8732-B16D415310B1Q33523269-5D5639EB-8757-4DAD-871F-31F4AAA53D02Q33585399-2BE3CA8F-5193-4BC5-9A3C-DB84392020BCQ33719308-9C39EA02-A49A-4E99-804C-7ADF62EC2A70Q33773392-41E3C631-DC2E-49CC-87BB-36EB6F2B1CB3Q34099242-934AEB19-865D-4FF4-930F-A6ECF7932BD2Q34114889-99C7E415-EE38-4604-B93C-41B11CF9EE67Q34480158-55592C4A-DF60-478C-BC3C-AD942616993AQ34519945-B458A8AD-7CA8-4FF4-88F0-FE225E4E8FC2Q34636937-D18C0975-E253-40A0-A8AF-D02DCC1C8F0BQ35207083-C869B250-1BA7-4EAA-ADA1-5765C8C3818CQ35670667-B89C7591-C4F9-473C-917A-66DDE76783F3Q35899448-A1AEC3FC-E696-41DC-B84D-88966C0285B8Q35920241-80B1672C-F843-4B9B-8BA4-FABA852C7261Q35984938-EF4E5DF1-B970-46F9-AF30-2ED825FC784FQ36670420-F48CDEB6-C821-4F89-8090-9D070E8156BEQ36813837-FF0EEC1E-0549-452B-9A1E-66CFC78FC324Q37114349-E033CECD-F16F-4B9D-9074-FA3462AF98A4Q37256378-6FB8DF8C-1957-4706-BF41-2FCC7B0012C1Q37440224-3717C5E9-908E-4DA6-AE0E-9EE13D42140EQ37611162-9B13C25D-91CD-4A1E-813A-9C21AF8BC76AQ37688805-19EFB66C-F3FC-480A-B0C1-D41A158D3617Q37716623-87179A7E-1EF9-4A5B-A608-985E7E3ED03EQ37979909-C6DBA916-5842-4967-B114-2062C32A306BQ38250450-128BD806-AE5A-489D-97E0-3C2276C59F06Q38894403-F3FBB749-2CEC-4FFE-9D8D-7ED1FB3375D8Q39372233-A822615B-D8AD-4830-B87B-0E1515293FC5Q39888463-B8C71FC3-0EB4-4C2E-A6D3-BF8AC9B47AD5Q40406803-50815B8C-A517-43B3-A600-559510C49AEDQ40420960-44177DBF-AF72-4E17-8E0B-51CF30641BA2Q41924502-619FC52A-81FB-491F-8C6F-A25AA6B40526Q42086987-5A86A7A9-DB0F-450E-A605-71AE1AB6199AQ43245092-FE8CB034-3643-43C5-82EB-A96AC9274659
P2860
Practical guidelines for multiplicity adjustment in clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Practical guidelines for multiplicity adjustment in clinical trials.
@ast
Practical guidelines for multiplicity adjustment in clinical trials.
@en
type
label
Practical guidelines for multiplicity adjustment in clinical trials.
@ast
Practical guidelines for multiplicity adjustment in clinical trials.
@en
prefLabel
Practical guidelines for multiplicity adjustment in clinical trials.
@ast
Practical guidelines for multiplicity adjustment in clinical trials.
@en
P1476
Practical guidelines for multiplicity adjustment in clinical trials.
@en
P2093
Proschan MA
Waclawiw MA
P304
P356
10.1016/S0197-2456(00)00106-9
P407
P577
2000-12-01T00:00:00Z